Therapeutic evaluation of herbal poultice (Ḍimād) in the management of pain and disability of chronic migraine: A case report
Abstract
Background: Chronic migraine ('Shaqīqa-i-Muzmin) is a common and disabling neurological condition affecting 1-3% of the global population. Esteemed Unāni physicians documented the use of an herbal poultice (Ḍimād) for treating chronic migraine. This case report describes the clinical outcomes of a patient with chronic migraine treated with a herbal poultice (Ḍimād).
Case presentation: A 45-year-old female presented to the Outpatient Department of Ilāj bi'l Tadbīr at Kashmir Tibbia College Hospital and Research Centre in Kashmir, India, with a 12-year history of chronic migraine. She experienced recurrent unilateral, throbbing headaches accompanied by nausea, photophobia, and phonophobia, occurring on approximately 18 days per month. Prior conventional treatments provided only temporary symptomatic relief. At baseline, her Visual Analogue Scale (VAS) score was 8/10, and her Migraine Disability Assessment Scale (MIDAS) score was 42, indicating severe disability.
Intervention and outcomes: The patient received treatment with an Ḍimād composed of Euphorbia resinifera Berg. (Farfiyūn), Ferula foetida Regel (Hiltīt), and Ferula galbaniflua Boiss. (Jāwshīr), prepared in sugarcane vinegar. The formulation was applied once daily to the forehead and right frontotemporal region for 28 consecutive days. After treatment, headache frequency dropped from 18 to 4 days per month, the VAS score improved from 8 to 2, and the MIDAS score decreased from 42 to 10. Associated symptoms were…
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.